摘要 |
<p>The present invention relates to a method for providing alpha -glucosidase inhibition to a subject by administering a pharmaceutical composition comprising a alpha -glucosidase inhibitory agent selected from pipataline (formula 1a), sesamin (formula 1b), pellitorine (Formula 1c), guineensine (Formula 1d) and brachystamide-B (formula 1e) having therapeutic application for diabetes mellitus, cancer, viral diseases such as hepatitis B and C, HIV, AIDS etc; also the invention provides a process for the isolation of said alpha -glucosidase inhibitory agent from the plant source Piper longum in significant yields.</p> |
申请人 |
COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH;RAO, JANASWAMY, MADHUSUDANA;SRINIVAS, PULLELA, VENKATA;ANURADHA, VUMMENTHALA;TIWARI, ASHOK, KUMAR;ALI, AMTUL, ZEHRA;YADAV, JHILLU, SINGH;RAGHAVAN, KONDAPURA, VIJAYA |
发明人 |
RAO, JANASWAMY, MADHUSUDANA;SRINIVAS, PULLELA, VENKATA;ANURADHA, VUMMENTHALA;TIWARI, ASHOK, KUMAR;ALI, AMTUL, ZEHRA;YADAV, JHILLU, SINGH;RAGHAVAN, KONDAPURA, VIJAYA |